Novel pathogenic VPS13A mutation in Moroccan family with Choreoacanthocytosis: A case report

3Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Choreoacanthocytosis (ChAc), is a rare neurodegenerative disease, characterized by movement disorders and acanthocytosis in the peripheral blood smears, and various neurological, neuropsychiatric and neuromuscular signs. It is caused by mutations in VPS13A gene with autosomal recessive pattern of inheritance. Case presentation: Here we report two patients belonging to a consanguineous Moroccan family who present with movement disorder pathology. They were suspected to have choreoacanthocytosis according to biological, clinical and radiological finding. Thus, whole-exome sequencing was performed for precise diagnosis and identified a homozygous novel nonsense mutation c.337C > T (p.Gln113*) in exon 5 of VPS13A in the two affected siblings. Conclusion: Here, we report a novel nonsense p.Gln113*mutation in VPS13A identified by whole-exome sequencing, which caused ChAc in a Moroccan family. This is the first description of ChAc in Morocco with genetic confirmation, that expands the mutation diversity of VPS13A and provide clinical, neuroimaging and deep brain stimulation findings.

Cite

CITATION STYLE

APA

Ouchkat, F., Regragui, W., Smaili, I., Naciri Darai, H., Bouslam, N., Rahmani, M., … Bouhouche, A. (2020). Novel pathogenic VPS13A mutation in Moroccan family with Choreoacanthocytosis: A case report. BMC Medical Genetics, 21(1). https://doi.org/10.1186/s12881-020-0983-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free